ArticleNeurology2021

Author Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.

Amit Bar-Or et al.PubMed ↗Publisher ↗

No numbers read from the abstract.